SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-043812
Filing Date
2013-08-08
Accepted
2013-08-08 09:32:03
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v350840_10q.htm 10-Q 409456
2 EXHIBIT 3.1 v350840_ex3-1.htm EX-3.1 74639
3 EXHIBIT 31.1 v350840_ex31-1.htm EX-31.1 9992
4 EXHIBIT 31.2 v350840_ex31-2.htm EX-31.2 9584
5 EXHIBIT 32.1 v350840_ex32-1.htm EX-32.1 4754
6 EXHIBIT 32.1 v350840_ex32-2.htm EX-32.2 4702
  Complete submission text file 0001144204-13-043812.txt   5131058

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nvax-20130630.xml EX-101.INS 406498
8 XBRL TAXONOMY EXTENSION SCHEMA nvax-20130630.xsd EX-101.SCH 39770
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20130630_cal.xml EX-101.CAL 49157
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20130630_def.xml EX-101.DEF 102177
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20130630_lab.xml EX-101.LAB 537271
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20130630_pre.xml EX-101.PRE 235704
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 131020211
SIC: 2836 Biological Products, (No Diagnostic Substances)